[Funding alert] Lenoss Medical Secures Investment from Xcellerant Ventures

Read also - Turkey-based Getir Completes Acquisition of FreshDirect

With the funding, the business hopes to further the development and commercialization of OsteoPearl, a biological option for treating osteoporotic vertebral compression fractures that doctors can prescribe.

Read also - Webster Financial Corporation Acquire Ametros Financial Corp

Lenoss, under the leadership of CEO Dom Messerli, is developing the OsteoPearl VBA System, that utilises minimally invasive, cement-free technology along with healthy bone's inherent healing abilities to provide a wholly biologic solution for stabilising spinal fractures.

About Lenoss Medical

Lenoss Medical, In vertebral body augmentation, a surgical tool is inserted into a broken vertebral body caused by osteoporosis or trauma. A device is inserted to fill the hollow and stabilise the fractured vertebrae once the cavity has been formed. A regenerative event takes place when a biologic is utilised to fill the void; new bone grows and the afflicted vertebrae gradually mend.

Read also - CA-based Distributional Secures $11m in Seed Funding